Pre-order Enquiry
Request Free Sample
Global Stereotactic-guided Biopsy Instrument Market Research Report 2021
SKU ID : QYR-17230677 | Publishing Date : 18-Jan-2021 | No. of pages : 117
Detailed TOC of Global Stereotactic-guided Biopsy Instrument Market Research Report 2021
1 Stereotactic-guided Biopsy Instrument Market Overview1.1 Product Overview and Scope of Stereotactic-guided Biopsy Instrument
1.2 Stereotactic-guided Biopsy Instrument Segment by Type
1.2.1 Global Stereotactic-guided Biopsy Instrument Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Needle-based Biopsy Instruments
1.2.3 Localization Wires
1.2.4 Procedure Trays
1.2.5 Others
1.3 Stereotactic-guided Biopsy Instrument Segment by Application
1.3.1 Stereotactic-guided Biopsy Instrument Sales Comparison by Application: (2021-2027)
1.3.2 Breast Biopsy
1.3.3 Lung Biopsy
1.3.4 Colorectal Biopsy
1.3.5 Prostate Biopsy
1.3.6 Others
1.4 Global Stereotactic-guided Biopsy Instrument Market Size Estimates and Forecasts
1.4.1 Global Stereotactic-guided Biopsy Instrument Revenue 2016-2027
1.4.2 Global Stereotactic-guided Biopsy Instrument Sales 2016-2027
1.4.3 Stereotactic-guided Biopsy Instrument Market Size by Region: 2016 Versus 2021 Versus 2027
2 Stereotactic-guided Biopsy Instrument Market Competition by Manufacturers
2.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Manufacturers (2016-2021)
2.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Stereotactic-guided Biopsy Instrument Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Stereotactic-guided Biopsy Instrument Manufacturing Sites, Area Served, Product Type
2.5 Stereotactic-guided Biopsy Instrument Market Competitive Situation and Trends
2.5.1 Stereotactic-guided Biopsy Instrument Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Stereotactic-guided Biopsy Instrument Players Market Share by Revenue
2.5.3 Global Stereotactic-guided Biopsy Instrument Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Stereotactic-guided Biopsy Instrument Retrospective Market Scenario by Region
3.1 Global Stereotactic-guided Biopsy Instrument Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Stereotactic-guided Biopsy Instrument Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Stereotactic-guided Biopsy Instrument Market Facts & Figures by Country
3.3.1 North America Stereotactic-guided Biopsy Instrument Sales by Country
3.3.2 North America Stereotactic-guided Biopsy Instrument Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Stereotactic-guided Biopsy Instrument Market Facts & Figures by Country
3.4.1 Europe Stereotactic-guided Biopsy Instrument Sales by Country
3.4.2 Europe Stereotactic-guided Biopsy Instrument Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Stereotactic-guided Biopsy Instrument Market Facts & Figures by Region
3.5.1 Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Region
3.5.2 Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Stereotactic-guided Biopsy Instrument Market Facts & Figures by Country
3.6.1 Latin America Stereotactic-guided Biopsy Instrument Sales by Country
3.6.2 Latin America Stereotactic-guided Biopsy Instrument Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Stereotactic-guided Biopsy Instrument Market Facts & Figures by Country
3.7.1 Middle East and Africa Stereotactic-guided Biopsy Instrument Sales by Country
3.7.2 Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Stereotactic-guided Biopsy Instrument Historic Market Analysis by Type
4.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Type (2016-2021)
4.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Type (2016-2021)
4.3 Global Stereotactic-guided Biopsy Instrument Price by Type (2016-2021)
5 Global Stereotactic-guided Biopsy Instrument Historic Market Analysis by Application
5.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Application (2016-2021)
5.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Application (2016-2021)
5.3 Global Stereotactic-guided Biopsy Instrument Price by Application (2016-2021)
6 Key Companies Profiled
6.1 C. R. Bard, Inc. (U.S.)
6.1.1 C. R. Bard, Inc. (U.S.) Corporation Information
6.1.2 C. R. Bard, Inc. (U.S.) Description and Business Overview
6.1.3 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2016-2021)
6.1.4 C. R. Bard, Inc. (U.S.) Product Portfolio
6.1.5 C. R. Bard, Inc. (U.S.) Recent Developments/Updates
6.2 Becton, Dickinson and Company (U.S.)
6.2.1 Becton, Dickinson and Company (U.S.) Corporation Information
6.2.2 Becton, Dickinson and Company (U.S.) Description and Business Overview
6.2.3 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Becton, Dickinson and Company (U.S.) Product Portfolio
6.2.5 Becton, Dickinson and Company (U.S.) Recent Developments/Updates
6.3 Cook Group Incorporated (U.S.)
6.3.1 Cook Group Incorporated (U.S.) Corporation Information
6.3.2 Cook Group Incorporated (U.S.) Description and Business Overview
6.3.3 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Cook Group Incorporated (U.S.) Product Portfolio
6.3.5 Cook Group Incorporated (U.S.) Recent Developments/Updates
6.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
6.4.1 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Corporation Information
6.4.2 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Description and Business Overview
6.4.3 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Product Portfolio
6.4.5 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Recent Developments/Updates
6.5 Argon Medical Devices (U.S.)
6.5.1 Argon Medical Devices (U.S.) Corporation Information
6.5.2 Argon Medical Devices (U.S.) Description and Business Overview
6.5.3 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Argon Medical Devices (U.S.) Product Portfolio
6.5.5 Argon Medical Devices (U.S.) Recent Developments/Updates
6.6 B. Braun Melsungen AG (Germany)
6.6.1 B. Braun Melsungen AG (Germany) Corporation Information
6.6.2 B. Braun Melsungen AG (Germany) Description and Business Overview
6.6.3 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2016-2021)
6.6.4 B. Braun Melsungen AG (Germany) Product Portfolio
6.6.5 B. Braun Melsungen AG (Germany) Recent Developments/Updates
6.7 Cardinal Health, Inc. (U.S.)
6.6.1 Cardinal Health, Inc. (U.S.) Corporation Information
6.6.2 Cardinal Health, Inc. (U.S.) Description and Business Overview
6.6.3 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cardinal Health, Inc. (U.S.) Product Portfolio
6.7.5 Cardinal Health, Inc. (U.S.) Recent Developments/Updates
6.8 Olympus Corporation (Japan)
6.8.1 Olympus Corporation (Japan) Corporation Information
6.8.2 Olympus Corporation (Japan) Description and Business Overview
6.8.3 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Olympus Corporation (Japan) Product Portfolio
6.8.5 Olympus Corporation (Japan) Recent Developments/Updates
6.9 Boston Scientific Corporation (U.S.)
6.9.1 Boston Scientific Corporation (U.S.) Corporation Information
6.9.2 Boston Scientific Corporation (U.S.) Description and Business Overview
6.9.3 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Boston Scientific Corporation (U.S.) Product Portfolio
6.9.5 Boston Scientific Corporation (U.S.) Recent Developments/Updates
6.10 FUJIFILM Holdings Corporation (Japan)
6.10.1 FUJIFILM Holdings Corporation (Japan) Corporation Information
6.10.2 FUJIFILM Holdings Corporation (Japan) Description and Business Overview
6.10.3 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2016-2021)
6.10.4 FUJIFILM Holdings Corporation (Japan) Product Portfolio
6.10.5 FUJIFILM Holdings Corporation (Japan) Recent Developments/Updates
6.11 INRAD, Inc. (U.S.)
6.11.1 INRAD, Inc. (U.S.) Corporation Information
6.11.2 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Description and Business Overview
6.11.3 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2016-2021)
6.11.4 INRAD, Inc. (U.S.) Product Portfolio
6.11.5 INRAD, Inc. (U.S.) Recent Developments/Updates
6.12 Medtronic plc (Ireland)
6.12.1 Medtronic plc (Ireland) Corporation Information
6.12.2 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Description and Business Overview
6.12.3 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Medtronic plc (Ireland) Product Portfolio
6.12.5 Medtronic plc (Ireland) Recent Developments/Updates
7 Stereotactic-guided Biopsy Instrument Manufacturing Cost Analysis
7.1 Stereotactic-guided Biopsy Instrument Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Stereotactic-guided Biopsy Instrument
7.4 Stereotactic-guided Biopsy Instrument Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Stereotactic-guided Biopsy Instrument Distributors List
8.3 Stereotactic-guided Biopsy Instrument Customers
9 Stereotactic-guided Biopsy Instrument Market Dynamics
9.1 Stereotactic-guided Biopsy Instrument Industry Trends
9.2 Stereotactic-guided Biopsy Instrument Growth Drivers
9.3 Stereotactic-guided Biopsy Instrument Market Challenges
9.4 Stereotactic-guided Biopsy Instrument Market Restraints
10 Global Market Forecast
10.1 Stereotactic-guided Biopsy Instrument Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Stereotactic-guided Biopsy Instrument by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Stereotactic-guided Biopsy Instrument by Type (2022-2027)
10.2 Stereotactic-guided Biopsy Instrument Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Stereotactic-guided Biopsy Instrument by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Stereotactic-guided Biopsy Instrument by Application (2022-2027)
10.3 Stereotactic-guided Biopsy Instrument Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Stereotactic-guided Biopsy Instrument by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Stereotactic-guided Biopsy Instrument by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Stereotactic-guided Biopsy Instrument Market Research Report 2021
List of TablesTable 1. Global Stereotactic-guided Biopsy Instrument Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Stereotactic-guided Biopsy Instrument Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Stereotactic-guided Biopsy Instrument Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Stereotactic-guided Biopsy Instrument Covered in This Study
Table 5. Global Stereotactic-guided Biopsy Instrument Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Stereotactic-guided Biopsy Instrument Sales Share by Manufacturers (2016-2021)
Table 7. Global Stereotactic-guided Biopsy Instrument Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Stereotactic-guided Biopsy Instrument Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Stereotactic-guided Biopsy Instrument Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Stereotactic-guided Biopsy Instrument Manufacturing Sites and Area Served
Table 11. Manufacturers Stereotactic-guided Biopsy Instrument Product Type
Table 12. Global Stereotactic-guided Biopsy Instrument Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Stereotactic-guided Biopsy Instrument by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stereotactic-guided Biopsy Instrument as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Stereotactic-guided Biopsy Instrument Sales by Region (2016-2021) & (K Units)
Table 16. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Region (2016-2021)
Table 17. Global Stereotactic-guided Biopsy Instrument Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Stereotactic-guided Biopsy Instrument Sales by Country (2016-2021) & (K Units)
Table 19. North America Stereotactic-guided Biopsy Instrument Sales Market Share by Country (2016-2021)
Table 20. North America Stereotactic-guided Biopsy Instrument Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Stereotactic-guided Biopsy Instrument Revenue Market Share by Country (2016-2021)
Table 22. Europe Stereotactic-guided Biopsy Instrument Sales by Country (2016-2021) & (K Units)
Table 23. Europe Stereotactic-guided Biopsy Instrument Sales Market Share by Country (2016-2021)
Table 24. Europe Stereotactic-guided Biopsy Instrument Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Stereotactic-guided Biopsy Instrument Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Stereotactic-guided Biopsy Instrument Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Stereotactic-guided Biopsy Instrument Revenue Market Share by Region (2016-2021)
Table 30. Latin America Stereotactic-guided Biopsy Instrument Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Stereotactic-guided Biopsy Instrument Sales Market Share by Country (2016-2021)
Table 32. Latin America Stereotactic-guided Biopsy Instrument Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Stereotactic-guided Biopsy Instrument Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Stereotactic-guided Biopsy Instrument Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Stereotactic-guided Biopsy Instrument Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue Market Share by Country (2016-2021)
Table 38. Global Stereotactic-guided Biopsy Instrument Sales (K Units) by Type (2016-2021)
Table 39. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Type (2016-2021)
Table 40. Global Stereotactic-guided Biopsy Instrument Revenue (Million US$) by Type (2016-2021)
Table 41. Global Stereotactic-guided Biopsy Instrument Revenue Share by Type (2016-2021)
Table 42. Global Stereotactic-guided Biopsy Instrument Price (USD/Unit) by Type (2016-2021)
Table 43. Global Stereotactic-guided Biopsy Instrument Sales (K Units) by Application (2016-2021)
Table 44. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Application (2016-2021)
Table 45. Global Stereotactic-guided Biopsy Instrument Revenue (Million US$) by Application (2016-2021)
Table 46. Global Stereotactic-guided Biopsy Instrument Revenue Share by Application (2016-2021)
Table 47. Global Stereotactic-guided Biopsy Instrument Price (USD/Unit) by Application (2016-2021)
Table 48. C. R. Bard, Inc. (U.S.) Corporation Information
Table 49. C. R. Bard, Inc. (U.S.) Description and Business Overview
Table 50. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product
Table 52. C. R. Bard, Inc. (U.S.) Recent Developments/Updates
Table 53. Becton, Dickinson and Company (U.S.) Corporation Information
Table 54. Becton, Dickinson and Company (U.S.) Description and Business Overview
Table 55. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Product
Table 57. Becton, Dickinson and Company (U.S.) Recent Developments/Updates
Table 58. Cook Group Incorporated (U.S.) Corporation Information
Table 59. Cook Group Incorporated (U.S.) Description and Business Overview
Table 60. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Product
Table 62. Cook Group Incorporated (U.S.) Recent Developments/Updates
Table 63. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Corporation Information
Table 64. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Description and Business Overview
Table 65. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Product
Table 67. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Recent Developments/Updates
Table 68. Argon Medical Devices (U.S.) Corporation Information
Table 69. Argon Medical Devices (U.S.) Description and Business Overview
Table 70. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Product
Table 72. Argon Medical Devices (U.S.) Recent Developments/Updates
Table 73. B. Braun Melsungen AG (Germany) Corporation Information
Table 74. B. Braun Melsungen AG (Germany) Description and Business Overview
Table 75. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Product
Table 77. B. Braun Melsungen AG (Germany) Recent Developments/Updates
Table 78. Cardinal Health, Inc. (U.S.) Corporation Information
Table 79. Cardinal Health, Inc. (U.S.) Description and Business Overview
Table 80. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product
Table 82. Cardinal Health, Inc. (U.S.) Recent Developments/Updates
Table 83. Olympus Corporation (Japan) Corporation Information
Table 84. Olympus Corporation (Japan) Description and Business Overview
Table 85. Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Product
Table 87. Olympus Corporation (Japan) Recent Developments/Updates
Table 88. Boston Scientific Corporation (U.S.) Corporation Information
Table 89. Boston Scientific Corporation (U.S.) Description and Business Overview
Table 90. Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Product
Table 92. Boston Scientific Corporation (U.S.) Recent Developments/Updates
Table 93. FUJIFILM Holdings Corporation (Japan) Corporation Information
Table 94. FUJIFILM Holdings Corporation (Japan) Description and Business Overview
Table 95. FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Product
Table 97. FUJIFILM Holdings Corporation (Japan) Recent Developments/Updates
Table 98. INRAD, Inc. (U.S.) Corporation Information
Table 99. INRAD, Inc. (U.S.) Description and Business Overview
Table 100. INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product
Table 102. INRAD, Inc. (U.S.) Recent Developments/Updates
Table 103. Medtronic plc (Ireland) Corporation Information
Table 104. Medtronic plc (Ireland) Description and Business Overview
Table 105. Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Product
Table 107. Medtronic plc (Ireland) Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Stereotactic-guided Biopsy Instrument Distributors List
Table 111. Stereotactic-guided Biopsy Instrument Customers List
Table 112. Stereotactic-guided Biopsy Instrument Market Trends
Table 113. Stereotactic-guided Biopsy Instrument Growth Drivers
Table 114. Stereotactic-guided Biopsy Instrument Market Restraints
Table 115. Global Stereotactic-guided Biopsy Instrument Sales Forecast by Type (2022-2027) & (K Units)
Table 116. Global Stereotactic-guided Biopsy Instrument Sales Market Share Forecast by Type (2022-2027)
Table 117. Global Stereotactic-guided Biopsy Instrument Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 118. Global Stereotactic-guided Biopsy Instrument Revenue Market Share Forecast by Type (2022-2027)
Table 119. Global Stereotactic-guided Biopsy Instrument Sales Forecast by Application (2022-2027) & (K Units)
Table 120. Global Stereotactic-guided Biopsy Instrument Sales Market Share Forecast by Application (2022-2027)
Table 121. Global Stereotactic-guided Biopsy Instrument Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 122. Global Stereotactic-guided Biopsy Instrument Revenue Market Share Forecast by Application (2022-2027)
Table 123. Global Stereotactic-guided Biopsy Instrument Sales Forecast by Region (2022-2027) & (K Units)
Table 124. Global Stereotactic-guided Biopsy Instrument Sales Market Share Forecast by Region (2022-2027)
Table 125. Global Stereotactic-guided Biopsy Instrument Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 126. Global Stereotactic-guided Biopsy Instrument Revenue Market Share Forecast by Region (2022-2027)
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Stereotactic-guided Biopsy Instrument
Figure 2. Global Stereotactic-guided Biopsy Instrument Market Share by Type in 2020 & 2027
Figure 3. Needle-based Biopsy Instruments Product Picture
Figure 4. Localization Wires Product Picture
Figure 5. Procedure Trays Product Picture
Figure 6. Others Product Picture
Figure 7. Global Stereotactic-guided Biopsy Instrument Market Share by Application in 2020 & 2027
Figure 8. Breast Biopsy
Figure 9. Lung Biopsy
Figure 10. Colorectal Biopsy
Figure 11. Prostate Biopsy
Figure 12. Others
Figure 13. Global Stereotactic-guided Biopsy Instrument Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Stereotactic-guided Biopsy Instrument Market Size 2016-2027 (US$ Million)
Figure 15. Global Stereotactic-guided Biopsy Instrument Sales 2016-2027 (K Units)
Figure 16. Global Stereotactic-guided Biopsy Instrument Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Stereotactic-guided Biopsy Instrument Sales Share by Manufacturers in 2020
Figure 18. Global Stereotactic-guided Biopsy Instrument Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Stereotactic-guided Biopsy Instrument Players: Market Share by Revenue in 2020
Figure 20. Stereotactic-guided Biopsy Instrument Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Region (2016-2021)
Figure 22. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Region in 2020
Figure 23. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Region (2016-2021)
Figure 24. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Region in 2020
Figure 25. U.S. Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. U.A.E Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Stereotactic-guided Biopsy Instrument by Type (2016-2021)
Figure 50. Sales Market Share of Stereotactic-guided Biopsy Instrument by Application (2016-2021)
Figure 51. Sales Market Share of Stereotactic-guided Biopsy Instrument by Application in 2020
Figure 52. Revenue Share of Stereotactic-guided Biopsy Instrument by Application (2016-2021)
Figure 53. Revenue Share of Stereotactic-guided Biopsy Instrument by Application in 2020
Figure 54. Manufacturing Cost Structure of Stereotactic-guided Biopsy Instrument
Figure 55. Manufacturing Process Analysis of Stereotactic-guided Biopsy Instrument
Figure 56. Stereotactic-guided Biopsy Instrument Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Keyplayers in Global Stereotactic-guided Biopsy Instrument Market Research Report 2021
C. R. Bard, Inc. (U.S.)Becton, Dickinson and Company (U.S.)
Cook Group Incorporated (U.S.)
Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
Argon Medical Devices (U.S.)
B. Braun Melsungen AG (Germany)
Cardinal Health, Inc. (U.S.)
Olympus Corporation (Japan)
Boston Scientific Corporation (U.S.)
FUJIFILM Holdings Corporation (Japan)
INRAD, Inc. (U.S.)
Medtronic plc (Ireland)
Request Sample
Request Discount
